Check out the companies making headlines after the bell:
Celgene's stock fell nearly 7 percent after hours. The company announced that it wouldn't be initiating a phase 3 test of a Crohn's disease drug.
Shares of Skechers surged nearly 23 percent in the extended session after the company posted higher-than-expected earnings and revenue for the third quarter.
Intuitive Surgical's stock fell more than 4 percent after the bell despite posting third-quarter revenue and profit that easily surpassed Wall Street expectations.
E*Trade Financial shares slid more than 2 percent in extended trading after the company posted revenue in line with Wall Street expectations.